© 2025 WKU Public Radio

Donate

Play Live Radio

Next Up:

0:00

0:00

0:00 0:00

Available On Air Stations

News

U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

By Scott Neuman

Published April 13, 2021 at 7:10 AM CDT

Tags

News health COVID-19 coronavirus vaccine coronavi Johnson & Johnson

Scott Neuman

Scott Neuman is a reporter and editor, working mainly on breaking news for NPR's digital and radio platforms.

See stories by Scott Neuman

Related Content

Health

After 12 Weeks Of Decline, Kentucky COVID-19 Cases Plateau

New cases of COVID-19 in Kentucky have plateaued following 12 weeks of declining cases, Gov. Andy Beshear said Monday. Infections are on the rise around…
Health

Vaccine Refusal May Put Herd Immunity At Risk, Researchers Warn

Geoff Brumfiel
Health

Kentucky Distillery Ultra-Cold Freezer on Loan to Regional Pharmacy for Pfizer Vaccine

It’s a match made in healthcare heaven, brought together by the spirits of Kentucky. That’s "spirits", as in bourbon. The Bard Distillery in Muhlenberg…
Health

Kentucky Slightly Exceeding National Vaccination Rate Even As Doses Go Unused

Lisa Autry

More than 1.5 million Kentuckians have so far received at least one dose of the COVID-19 vaccine, but when it comes to fully vaccinated individuals, rates…
Health

FAQ: What Is A Vaccine 'Passport,' And What Are These Credentials Used For?

Laurel Wamsley